PortfoliosLab logoPortfoliosLab logo
LAZ vs. GILD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LAZ vs. GILD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lazard Ltd (LAZ) and Gilead Sciences, Inc. (GILD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LAZ achieves a -8.51% return, which is significantly lower than GILD's 7.50% return. Both investments have delivered pretty close results over the past 10 years, with LAZ having a 8.21% annualized return and GILD not far behind at 7.93%.


LAZ

1D
0.16%
1M
-0.16%
6M
-17.49%
YTD
-8.51%
1Y
-15.69%
3Y*
11.90%
5Y*
4.72%
10Y*
8.21%
ALL TIME*
6.57%

GILD

1D
0.05%
1M
4.38%
6M
2.19%
YTD
7.50%
1Y
21.39%
3Y*
21.28%
5Y*
17.78%
10Y*
7.93%
ALL TIME*
18.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$776.83M$985.51M$985.01M
$75.66M$81.64M$91.44M

LAZ vs. GILD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LAZ
Lazard Ltd
-8.51%-1.64%54.83%6.92%-16.21%7.41%12.08%15.22%-25.38%36.20%
GILD
Gilead Sciences, Inc.
7.50%36.59%18.68%-1.99%23.63%29.95%-6.70%7.88%-9.92%2.96%

Correlation

The correlation between LAZ and GILD is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since May 5, 2005

0.29

Over the past year, the correlation between LAZ and GILD has dropped to 0.05 - well below their long-term average of 0.29, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

LAZ:

$4.29B

GILD:

$161.83B

EPS

LAZ:

$2.60

GILD:

$7.35

PE Ratio

LAZ:

16.78

GILD:

17.73

PS Ratio

LAZ:

1.42

GILD:

5.50

PB Ratio

LAZ:

5.28

GILD:

6.95

Total Revenue (TTM)

LAZ:

$3.28B

GILD:

$29.74B

Gross Profit (TTM)

LAZ:

$1.54B

GILD:

$18.74B

EBITDA (TTM)

LAZ:

$477.61M

GILD:

$12.88B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LAZ vs. GILD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LAZ
LAZ Risk / Return Rank: 2727
Overall Rank
LAZ Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
LAZ Sortino Ratio Rank: 2727
Sortino Ratio Rank
LAZ Omega Ratio Rank: 2828
Omega Ratio Rank
LAZ Calmar Ratio Rank: 2727
Calmar Ratio Rank
LAZ Martin Ratio Rank: 2424
Martin Ratio Rank

GILD
GILD Risk / Return Rank: 6767
Overall Rank
GILD Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
GILD Sortino Ratio Rank: 6868
Sortino Ratio Rank
GILD Omega Ratio Rank: 6464
Omega Ratio Rank
GILD Calmar Ratio Rank: 6666
Calmar Ratio Rank
GILD Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LAZ vs. GILD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lazard Ltd (LAZ) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LAZGILDDifference
Sharpe ratioReturn per unit of total volatility

-1.18

Sortino ratioReturn per unit of downside risk

-1.68

Omega ratioGain probability vs. loss probability

0.96

1.15

-0.19

Calmar ratioReturn relative to maximum drawdown

-0.50

1.00

-1.50

Martin ratioReturn relative to average drawdown

-0.99

2.34

-3.33

LAZ vs. GILD - Sharpe Ratio Comparison

The current LAZ Sharpe Ratio is -0.39, which is lower than the GILD Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of LAZ and GILD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LAZ vs. GILD - Drawdown Comparison

The maximum LAZ drawdown since its inception was -62.72%, smaller than the maximum GILD drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for LAZ and GILD.


Loading charts...

Drawdown Indicators


LAZGILDDifference

Max Drawdown

Largest peak-to-trough decline

-62.72%

-70.83%

+8.11%

Max Drawdown (1Y)

Largest decline over 1 year

-31.39%

-21.59%

-9.80%

Max Drawdown (3Y)

Largest decline over 3 years

-44.24%

-26.59%

-17.65%

Max Drawdown (5Y)

Largest decline over 5 years

-44.24%

-26.59%

-17.65%

Max Drawdown (10Y)

Largest decline over 10 years

-59.51%

-30.47%

-29.04%

Current Drawdown

Current decline from peak

-23.41%

-15.31%

-8.10%

Average Drawdown

Average peak-to-trough decline

-23.50%

-22.14%

-1.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.88%

9.16%

+6.72%

Volatility

LAZ vs. GILD - Volatility Comparison

Lazard Ltd (LAZ) has a higher volatility of 13.02% compared to Gilead Sciences, Inc. (GILD) at 10.00%. This indicates that LAZ's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LAZGILDDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.02%

10.00%

+3.02%

Volatility (6M)

Calculated over the trailing 6-month period

34.41%

19.91%

+14.50%

Volatility (1Y)

Calculated over the trailing 1-year period

40.46%

27.30%

+13.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.65%

24.52%

+13.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.96%

25.60%

+10.36%

Dividends

LAZ vs. GILD - Dividend Comparison

LAZ's dividend yield for the trailing twelve months is around 4.59%, more than GILD's 2.47% yield.


PositionTTM20252024202320222021202020192018201720162015
GILD
Gilead Sciences, Inc.
2.47%2.57%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%
LAZ
Lazard Ltd
4.59%4.12%3.89%5.75%5.60%4.31%4.44%5.88%8.21%5.35%6.55%5.22%

Financials

LAZ vs. GILD - Financials Comparison

This section allows you to compare key financial metrics between Lazard Ltd and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
779.40M
6.96B
(LAZ) Total Revenue
(GILD) Total Revenue
Values in USD except per share items

LAZ vs. GILD - Profitability Comparison

The chart below illustrates the profitability comparison between Lazard Ltd and Gilead Sciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
100.0%
1.1%
Portfolio components
LAZ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Lazard Ltd reported a gross profit of 779.40M and revenue of 779.40M. Therefore, the gross margin over that period was 100.0%.

GILD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.

LAZ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Lazard Ltd reported an operating income of 112.39M and revenue of 779.40M, resulting in an operating margin of 14.4%.

GILD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.

LAZ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Lazard Ltd reported a net income of 100.92M and revenue of 779.40M, resulting in a net margin of 13.0%.

GILD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.


Frequently Asked Questions


LAZ and GILD have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LAZ has higher volatility (13.02%) compared to GILD (10.00%). In terms of maximum drawdown, LAZ dropped -62.72% vs GILD's -70.83%.

GILD currently has the higher Sharpe Ratio (0.79 vs -0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LAZ and GILD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer